ANI Names Vice President, Corticotropin Product Development
Executive Summary
ANI Pharmaceuticals, Inc. has appointed Mark J. Ginski vice president, corticotropin product development. Ginski brings over 20 years of industry experience to the integrated specialty pharma company, most recently within Mallinckrodt Pharmaceuticals, where he was senior director, CMC and operations for autoimmune and rare diseases. Prior to this, he held various positions in the area of specialty drug development at Shire Pharmaceuticals, Alba Therapeutics, Cerecor Inc. and Questcor Pharmaceuticals.